PRINCIPAL FINANCIAL GROUP INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 323 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,026,434
-77.9%
26,983
-47.0%
0.00%
-66.7%
Q2 2023$4,642,091
+175.6%
50,956
+99.5%
0.00%
+200.0%
Q1 2023$1,684,619
-55.4%
25,540
-65.0%
0.00%
-66.7%
Q4 2022$3,773,900
+120.6%
72,982
+191.4%
0.00%
+200.0%
Q3 2022$1,711,000
+49.8%
25,046
-0.8%
0.00%0.0%
Q2 2022$1,142,000
-7.5%
25,250
+3.9%
0.00%0.0%
Q1 2022$1,235,000
+15.5%
24,304
+7.5%
0.00%0.0%
Q4 2021$1,069,000
+8.4%
22,608
-24.4%
0.00%0.0%
Q3 2021$986,000
-46.1%
29,909
+3.4%
0.00%0.0%
Q2 2021$1,828,000
+43.8%
28,937
-2.3%
0.00%0.0%
Q1 2021$1,271,000
-27.9%
29,609
-3.9%
0.00%0.0%
Q4 2020$1,763,000
+133.8%
30,824
+23.3%
0.00%0.0%
Q3 2020$754,000
-11.7%
24,992
-4.4%
0.00%0.0%
Q2 2020$854,000
+231.0%
26,144
+171.9%
0.00%
Q1 2020$258,000
-9.5%
9,616
+3.4%
0.00%
Q4 2019$285,000
+35.1%
9,298
+6.1%
0.00%
Q3 2019$211,000
-3.7%
8,767
+1.4%
0.00%
Q2 2019$219,0008,6470.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,160,000$163,403,60025.44%
Avoro Capital Advisors LLC 10,625,000$549,418,7508.21%
Logos Global Management LP 1,350,000$69,808,5008.18%
EcoR1 Capital, LLC 5,183,431$268,035,2178.16%
Saturn V Capital Management LP 212,329$9,414,3197.81%
ACUTA CAPITAL PARTNERS, LLC 217,500$11,246,9256.92%
Ghost Tree Capital, LLC 300,000$15,513,0006.62%
Finepoint Capital LP 334,890$17,3175.60%
Cormorant Asset Management, LP 1,576,872$81,5405.46%
Tri Locum Partners LP 221,897$11,474,0004.64%
View complete list of APELLIS PHARMACEUTICALS INC shareholders